Tag: immunotherapy

  • Buddisode 36 – IL-17A and ICI-induced autoimmune thyroiditis

    In this Buddisode, we sit down with Dr. Melissa Lechner from the Division of Endocrinology, Diabetes, and Metabolism at the UCLA David Geffen School of Medicine to discuss her recent paper about the mechanisms behind immune checkpoint inhibitor-induced autoimmune thyroiditis. Check out our memes on Facebook (@antibuddies), Twitter (@antibuddiesP), and Instagram (@AntibuddiesPodcast). Website: Antibuddies – Science […]

  • Buddisode 15 – Mitochondria is the powerhouse of TILs

    In this buddisode, we sit down with Dr. Yi-ru Yu, a post doctoral researcher at the department of oncology (University of Lausanne, Switzerland) to talk about his recent article studying mitochondrial dynamics in the exhaustion of tumor infiltrating lymphocytes (TILs). Check out our memes on Facebook (@antibuddies) and Twitter (@antibuddiesP). Website: Antibuddies – Science Communication & […]

  • Monolog 1 – No mercy for cancer

    In this monolog, Jatin briefly discusses the recent study from Lai et al. about FLT3L-secreting CAR T cells that successfully elicited a polyclonal immune response in Her2 and OVA co-expressing tumor models. Check out our memes on Facebook (@antibuddies) and Twitter (@antibuddiesP). Website: Antibuddies – Science Communication & Immunology (Antibuddies.org) Join us on our monthly journal […]

  • Buddisode 9 – Cancer nano-immunotherapy #2

    In this Buddisode, Antia and Jatin continue to discuss about the recent developments in cancer nano medicine. Check out our memes on Facebook (@antibuddies) and Twitter (@antibuddiesP). Website: Antibuddies – Science Communication & Immunology (Antibuddies.org) Send us your queries/questions/suggestions at antibuddies1@gmail.com. Sources: https://www.nature.com/articles/s41577-019-0269-6

  • Buddisode 8 – Cancer nano-immunotherapy #1

    In this Buddisode, Antia and Jatin discuss about the recent developments in cancer nano medicine. Part 2 will be out soon. Check out our memes on Facebook (@antibuddies) and Twitter (@antibuddiesP). Website: Antibuddies – Science Communication & Immunology (Antibuddies.org) Send us your queries/questions/suggestions at antibuddies1@gmail.com. Check out Public journal club here https://www.facebook.com/Publicjournalclub/ Sources: https://www.nature.com/articles/s41577-019-0269-6

  • Sugar, yes please, won’t you come and put it down on macrophage: A song of sugars and cancers

    Sugar, yes please, won’t you come and put it down on macrophage: A song of sugars and cancers

    Our immune system is a well-orchestrated fort, equipped to fight all kinds of nasty that attack our body. Unfortunately, some attackers come well prepared with weapons for immune evasion and can escape or even confuse our immune system, such as with cancer. In the recent years, we have seen a rise of new potential therapies […]

  • A Camel to the Rescue: Nanobodies against SARS-CoV-2

    A Camel to the Rescue: Nanobodies against SARS-CoV-2

    Created with BioRender.com Amid the COVID-19 pandemic, antibodies have been under the spotlight as potential therapeutics. Antibodies patrol the body and bind to their specific target region, known as an epitope, on an antigen. In humans, antibodies consist of 2 heavy chains and 2 light chains held together by disulfide bonds (see graphical abstract). However, as […]

  • Toxoplasma gondii – a new cancer fighting superhero

    Toxoplasma gondii – a new cancer fighting superhero

    “Life will win over death, and light will win over darkness”– Volodymyr Zelenskyy, President of Ukraine “I would not be here today if it wasn’t for you and your discovery” – said Tomas Dahl during the meeting in Stockholm. Tomas was one of the cancer patients who had the prestigious chance to share their story […]

  • A step towards affordable cell therapy using mRNA technology

    A step towards affordable cell therapy using mRNA technology

    This image was created with Biorender.com A decade ago, a novel immunotherapy ravaged two pounds of cancer cells and revolutionized the treatment of blood cancer. This immunotherapy isolated T cells from a patient and inserts a gene encoding synthetic chimeric antigen receptor (CAR) ex-vivo into T cells. These CARs contain regions to redirect T cells […]

  • A Combo offer to deal with Melanoma: Latest Development with Immune Checkpoint Inhibitors

    A Combo offer to deal with Melanoma: Latest Development with Immune Checkpoint Inhibitors

    Modern Science has experienced huge breakthroughs over the last decades, one of the major ones being the discovery of immune checkpoints and their inhibitors. The checkpoint inhibitors revolutionized the stagnant field of cancer biology and were responsible for the rise of cancer immunotherapies. Immunotherapies command the immune system to destroy tumors by using antibodies against […]